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Abstract
Background: Hadron therapy is an innovative technique where cancer cells are precisely killed leaving surrounding
healthy cells least affected by high linear energy transfer (LET) radiation like carbon ion beam. Anti-metastatic effect of
carbon ion exposure attracts investigators into the field of hadron biology, although details remain poor. Poly(ADP-ribose)
polymerase-1 (PARP-1) inhibitors are well-known radiosensitizer and several PARP-1 inhibitors are in clinical trial. Our
previous studies showed that PARP-1 depletion makes the cells more radiosensitive towards carbon ion than gamma. The
purpose of the present study was to investigate combining effects of PARP-1 inhibition with carbon ion exposure to
control metastatic properties in HeLa cells.
Methods: Activities of matrix metalloproteinases-2, 9 (MMP-2, MMP-9) were measured using the gelatin zymography
after 85 MeV carbon ion exposure or gamma irradiation (0- 4 Gy) to compare metastatic potential between PARP-1
knock down (HsiI) and control cells (H-vector - HeLa transfected with vector without shRNA construct). Expression of
MMP-2, MMP-9, tissue inhibitor of MMPs such as TIMP-1, TIMP-2 and TIMP-3 were checked by immunofluorescence
and western blot. Cell death by trypan blue, apoptosis and autophagy induction were studied after carbon ion
exposure in each cell-type. The data was analyzed using one way ANOVA and 2-tailed paired-samples T-test.
Results: PARP-1 silencing significantly reduced MMP-2 and MMP-9 activities and carbon ion exposure further
diminished their activities to less than 3 % of control H-vector. On the contrary, gamma radiation enhanced both MMP-
2 and MMP-9 activities in H-vector but not in HsiI cells. The expression of MMP-2 and MMP-9 in H-vector and HsiI
showed different pattern after carbon ion exposure. All three TIMPs were increased in HsiI, whereas only TIMP-1 was
up-regulated in H-vector after irradiation. Notably, the expressions of all TIMPs were significantly higher in HsiI than H-
vector at 4 Gy. Apoptosis was the predominant mode of cell death and no autophagic death was observed.
Conclusions: Our study demonstrates for the first time that PARP-1 inhibition in combination with carbon ion
synergistically decreases MMPs activity along with overall increase of TIMPs. These data open up the possibilities of
improvement of carbon ion therapy with PARP-1 inhibition to control highly metastatic cancers.
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Background
Metastasis is the advance stage of cancer progression
with high morbidity leading to death of patients. In
metastatic stage, cancer cells spread from their primary
sites to the neighboring cells or to a distant organ by
achieving migratory and invasiveness properties. Finally,
they become able to get direct access to blood and
lymphatic vessels [1–3]. During this tumor invasion and
metastasis, several matrix metalloproteinases (MMPs)
like MMP-2 and MMP-9 play a critical role by degrading
the extracellular matrix and components of the base-
ment membrane [4–6]. These two are gelatinase (which
can degrade gelatin) in nature and are found in large
quantities in various cancer tissues suggesting their role
in cancer progression [7–10]. Activity of MMPs is one
of the major determining factors of metastasis. Regula-
tion of their activities is precisely maintained at the level
of transcription, activation of pro-MMP precursor zymo-
gens and inhibition by endogenous inhibitors, called tis-
sue inhibitors of metalloproteinases (TIMPs) [11, 12].
Literature review expresses that overexpression and
hyperactivity of MMP-2 and MMP-9 has been observed
in pre-cancer and cancer lesions of all kinds of cancers
including the uterine cervical cancer which is second
most common malignant tumor among female in the
developing countries [13–22]. Detailed studies are
needed to elucidate the molecular mechanism of cancer
progression and thereby search for the better molecular
targets to control such aggressive form of cancer.
Radiotherapy mainly by low linear energy transfer
(LET) radiation like X-rays & gamma rays have been an
important treatment tool for many malignant tumors
but it has a number of limitations. One of the limitations
is - such type of ionizing radiation can enhance the
metastatic nature in various kinds of cancer cells by in-
creasing the expression as well as activities of MMP-2
and MMP-9 leading to great difficulties in radiotherapy.
A number of studies showed the increased expression
and activities of MMP-2 and MMP-9 after X-ray irradi-
ation [23–25]. Up-regulation of MMP-2 and MMP-9 ac-
tivity was also observed in TGF-beta 1 transgenic mouse
model after thoracic irradiation [26]. Protein expression
level of TIMP-1 and TIMP-2 was also found to be al-
tered in a complex manner after gamma or X-rays impli-
cating that MMPs and TIMPs are of great concern in
radiotherapy [27–29]. High LET particle radiations are
very much useful and advantageous over low LET radia-
tions for radiotherapy purposes due to its characteristic
energy deposition at Bragg’s Peak and dose-depth distri-
bution, higher relative biological effectiveness (RBE)
value, independent of oxygen requirement and cell cycle
phases etc [30]. Such charged particles produce huge
double strand DNA breaks in a close proximity - known
as ‘cluster DNA damage’ unlike to low LET radiation
and consequently have different downstream DNA dam-
age responses from low LET radiation [31]. High LET
charged particles not only show higher cell killing but
also inhibit MMPs activities and help to block cancer
metastasis although detailed mechanism is still not clear
[32–34].
One of the immediate responses after DNA damage by
ionizing radiation is the activation of poly(ADP-ribosy-
l)ation reaction predominantly by the poly(ADP-ribose)
polymerase-1 or PARP-1, a well- known DNA base exci-
sion repair protein [35]. It has diversified roles in various
biological and physiological processes like- maintenance
of chromatin structure, cell cycle regulation, transcrip-
tion regulation, apoptosis, inflammation etc [36]. Since
PARP-1 is involved in DNA repair process, its inhibitors
have been used as chemo-sensitizer or radio-sensitizer
and are in clinical trial to treat BRCA1/2 mutant breast
cancer cells [37, 38]. There are various PARP-1 inhibi-
tors that are in clinical trial for different kinds of cancers
[39–42]. The role of PARP-1 in ‘cluster DNA damage’
condition by high LET radiation is still under investiga-
tion. Inhibition of PARP-1 shows higher radio-
sensitization towards high LET carbon ion beam than
low LET gamma radiation as reported by us as well as
Takahisa et al. [43, 44]. Furthermore, we showed that
knocking down of PARP-1 gene by shRNA can trigger
several apoptotic parameters leading to more apoptosis
after ‘cluster DNA damage’ by high LET carbon beam
[45]. There is a substantial number of studies indicating
a cross talk between PARP-1 and matrix metalloprotein-
ases (MMPs). Inhibition of PARP by pharmacological
inhibitor or siRNA can down-regulate MMP-9 and
MMP-2 expressions as well as their enzymatic activities
[46–48]. But cross talk between PARP-1 and MMPs/
TIMPs in cells irradiated with carbon ion beam is not
known. Here, we have investigated the status of MMPs
and TIMPs in cultured HeLa cells irradiated with carbon
ion beam in combination with PARP-1 depletion.
Materials and methods
Chemical and antibodies
Bovine serum albumin (BSA), trypan blue, ethidium
bromide, paraformaldehyde were purchased from
Sigma-Aldrich, USA; Sodium dodecyl sulfate (SDS) from
Boeringer Mannheim, Germany; Trypsin and hygromy-
cin B from HiMedia, India; Triton X-100 and glycine
from SRL, India. Other bio-chemicals and reagents of
molecular biology grade used in this study were pur-
chased locally.
The primary antibodies were purchased from Santa
Cruz Biotechnology Inc, USA such as mouse anti-PARP-
1 [sc-74469], mouse anti-MMP-2 [sc-80201], mouse
anti-MMP-9 [sc-58389], mouse anti-TIMP-1 [sc-80365],
mouse anti-TIMP-2 [sc-80366] and mouse anti-TIMP-3
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[sc-80367]. Rabbit anti-beta actin [ab151526] was from
Abcam, UK. Mouse anti-MMP-2 antibody [Cat No-
436000] and rabbit anti-caspase-3 [Cat No- 700182] were
purchased from Invitrogen, USA. Secondary antibodies
used for immunofluorescence (IF) were goat anti-mouse
IgG1-FITC [sc-2078], donkey anti-mouse IgG-FITC [sc-
2099] and donkey anti-rabbit IgG-R [sc-2095] from Santa
Cruz Biotechnology Inc., USA. Anti-mouse IgG, HRP-
linked antibody [Product#7076] was obtained from Cell
Signaling Technology, Inc., USA for western blot. VisGlow
plus Chemiluminescent Substrate of HRP (Visual Protein
Biotechnology Corp, Taiwan) was used for developing
western blots.
Cell culture
Human cervical cancer cell line HeLa was obtained from
National Centre for Cell Sciences (NCCS), Pune, India.
HeLa cells were grown in DMEM supplemented with
10 % bovine serum (complete medium) at 37 °C in
humidified atmosphere containing 5 % CO2.
Preparation of PARP-1 knocked down cells
PARP-1 knocked down HeLa cells were prepared using
lipofectamine 2000TM (Invitrogen, USA) mediated stable
transfection procedure with shRNA construct against
PARP-1 in plasmid pRNA-U6.1 (GeneScript, USA)
followed by our earlier method [45]. PARP-1 shRNA
transfected cells are denoted as HsiI and the negative
control cells (only vector plasmid without shRNA insert
was used for transfection) are termed as H-vector. All
experiments using transfected cells were done within 3-
4 passages of cells.
Irradiation with carbon ion and gamma ray
We used the Radiation Biology Laboratory of Inter Uni-
versity Accelerator Centre (IUAC), New Delhi, India to
grow the cells and subsequently irradiated it with carbon
ion beam in the heavy ion irradiation facility ASPIRE as
mentioned in [49]. Cells were seeded at a density of 0.5 ×
106 cells/plate on 35 mm petri dishes (Nunc, USA). The
energy of carbon ion beam from the Pelletron Accelerator
was 85 MeV (equivalent to 7.08 MeV/nucleon). The en-
ergy of the beam on the cell surface was 62 MeV (equiva-
lent 5.16 MeV/nucleon) with entrance LET 287 keV/μm
as calculated by TRIM software. The beam flux was main-
tained at about 2 × 105 particles/cm2/s. The dose in Gy
was calculated using the standard relation given below,
where the cell is taken to be water equivalent.
Dose Gyð Þ ¼ 1:6  10‐9  LET keV=μmð Þ
 Fluence particles=cm2 :
The irradiation dose range used was from 0 to 4 Gy,
where 0 Gy stood for the control sample. Prior to the
exposure to the ion beam the cells were grown for 10–
12 h inside the CO2 incubator till they reached 50–60 %
confluent. Immediately after irradiation, cells were taken
back to bio-safety cabinet and washed with phosphate
buffered saline (PBS) for three times. Then 1 ml serum
free medium for zymography experiment otherwise 2 ml
serum free medium was added to the each plate and in-
cubated in CO2 incubator for further 18–20 h. The sam-
ples were then prepared for the zymography or
processed for other experiments following the methods
as described later.
The cells were also irradiated with different doses
(0- 4 Gy) of gamma ray [Co60] at Saha Institute of
Nuclear Physics, Kolkata, India as mentioned in [43].
The dose rate was 0.47 Gy/min. After irradiation cells
were processed according to the procedure as de-
scribed above for respective experiments.
Total cell death by trypan blue
Total cell death after carbon ion exposure (0- 4 Gy)
followed by 19 h incubation in serum free medium was
measured by dye exclusion method using 0.2 % trypan
blue. The blue colored cells denote dead cells. Percent-
ages of dead cells were calculated and plotted.
Study of MMP-2 & MMP-9 activities by gelatin
zymography
Gelatin zymography was done to assess MMP-2 and
MMP-9 activity [50]. Almost 40 % confluent cells (for H-
vector and HsiI) were seeded for 10–12 h growth in
complete medium. After irradiation with carbon ion or
gamma ray (0- 4 Gy) the cells were washed thrice with
PBS and incubated in 1 ml of serum free medium for
19 h. Now, these conditioned medium were collected,
centrifuged to remove cellular debris, and concentrated by
centrifugation through Amicon membrane (Millipore),
with a cutoff of 30 kDa. Then protein concentrations were
determined by Lowry’s method. Equal amount of protein
was subjected to 0.1 % gelatin 8 % SDS-PAGE under non-
reducing conditions. The gel was run for 2 h at 4 °C until
the bromophenol blue dye comes out from the gel. Then
gel was washed in 2.5 % Triton X-100 for 1 h with con-
stant shaking and washed with double distilled water
for three times with 20 min interval in shaking condi-
tion. After that gel was incubated in developing buffer
(Tris-Cl2, pH- 7.5, NaCl, CaCl2 and Brij-35) for
30 min shaking at room temperature and finally the gel
was kept in fresh developing buffer for overnight at 37 °C.
After 23 h incubation gels were stained with 0.1 % Coo-
massie blue for 1 h and destained in 10 % methanol and
10 % acetic acid. Zones of gelatinolytic activity were de-
tected as clear bands against a blue background. A parallel
SDS-PAGE without gelatin was run loaded with same
amount of sample under same experimental condition
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and was treated as internal loading control (shown in
Additional file 1) with respect to which the band inten-
sities of zymography was normalized and plotted in bar
diagram.
Protein expression of PARP-1, MMP-2, MMP-9, TIMP-1,
TIMP-2 & TIMP-3 by immunofluorescence (IF) study
Protein expression of PARP-1, MMP-2, MMP-9, TIMP-
1, TIMP-2 & TIMP-3 with and without carbon ion ex-
posure (0- 4 Gy) in both H-vector and HsiI cells was
studied by standard IF technique as described in our re-
cent article [45]. Cells were processed after 19 h of ir-
radiation. Images were captured using monochrome
camera in AxioScope AI of Carl Zeiss Fluorescence
Microscope. Then these images were converted into
RGB mode by putting pseudo-colour using Zen software
of Carl Zeiss, Germany. Intensities were measured by
ImageJ software [45, 51]. Expression level of these pro-
teins were then normalized against the expression of
beta-actin. Expression of respective protein in un-
irradiated control H-vector was considered as 100 % to
calculate the protein expression in all the data point in a
respective experiment. For each data point at least 250
cells were analyzed.
The primary antibodies used were mouse anti-PARP-1
(1:150), mouse anti-MMP-2 (1:200), mouse anti-MMP-9
(1:200), mouse anti-TIMP-1 (1:200), mouse anti-TIMP-2
(1:200), mouse anti-TIMP-3 (1:200) and rabbit anti-beta
actin (1:900). Secondary antibodies used were goat anti-
mouse IgG1-FITC, donkey anti-mouse IgG-FITC and
donkey anti-rabbit IgG-R (Rhodamine tagged). The dilu-
tion for secondary antibodies was 1:400.
Western blotting for MMP-2
Whole cell lysate was prepared for western blotting
using the method as described in [52]. In brief, after
19 h post-carbon ion or gamma exposure (0- 4 Gy) cells
were washed with PBS twice followed by trypsinization
and again washed with 1 ml of wash buffer (HEPES-
KOH 10 mM, pH 7.5, MgCl2 1.5 mM, KCl 10 mM, DTT
1 mM). Then cell lysis was done using the lysis buffer
(Tris-Cl 10 mM pH 7.5, MgCl2 1 mM, EGTA 1 mM, β-
mercaptoethanol 0.75 %, CHAPS 0.5 %, glycerol 10 %) in
ice for 30 min. Clear supernatant was obtained after cen-
trifugation at 12,000 g for 15 min at 4 °C. Protein con-
tent was estimated by standard Lowry’s method. 30 μg of
protein was separated in standard 10 % SDS-PAGE in
1X Tris glycine buffer (25 mM Tris, 250 mM glycine,
0.1 % SDS) at 120 V. After completion of electrophoretic
run, the protein gel was processed for immunoblotting as
our earlier report with slight modification [52]. The con-
centrations of antibodies used were mouse anti-MMP-2
antibody (1:2500), rabbit anti-beta actin (1:10000) and
HRP-conjugated secondary antibody (1:5000). Finally, the
blot was developed using VisGlow plus Chemiluminescent
Substrate of HRP. The signals from the blots were cap-
tured by Typhoon 9210 – Variable Mode Imager (GE
Healthcare, USA).
Autophagy detection by IF
Autophagy is a self-eating process and this kind of cell
death can be triggered under several cellular stresses like
starvation, pH change etc. including DNA damages. Autop-
hagolysosomes or autolysosomes, double-membrane bound
vesicles like structures, are produced in the cells to engulf
the intracellular damaged organelles or aggregated proteins
by lysosome-mediated process and finally degraded by lyso-
somal hydrolases [53, 54]. Here, LC3B protein plays a crit-
ical role for proper processing of autophagy. Generally, this
protein is found in cytosol, but during autophagy this pro-
tein localizes to the autophagolysosomes or autolysosomes.
Such phenomenon is used as a marker for autophagic
membrane. We used LC3B Antibody Kit for Autophagy
(Molecular Probes, Invitrogen, USA) detection following
the protocol given by the manufacturer through IF tech-
nique [55]. Chloroquine diphosphate, an inducer of autoph-
agy, was also used as positive control as supplied by the
manufacturer.
Apoptosis as detected by activation of caspase-3 and nu-
clear fragmentation
Caspase-3 activation in both H-vector and HsiI cells
after carbon ion exposure (0- 4 Gy) was detected
through IF following the procedure as described in our
previous work [45]. Here the antibody used for caspase-
3 detection was specific for the cleaved active form of
caspase-3 with dilution 1:300. Cells were processed after
20 h of post-irradiation incubation. Donkey anti-rabbit
IgG-R (Rhodamine) was used as secondary antibody. We
also measured caspase-3 activity by fluorimetric study.
After 16- 18 h growth, cells were irradiated with carbon
ion exposure (0- 4 Gy) and further incubated in serum
free medium for another 20 h. Cells were counted by
Countess (Invitrogen, USA) after trypsinization. Two
million cells were taken to assay the caspase-3 activity
using the protocol provided by the manufacturer (ApoA-
lert® Caspase 3 Fluorescence Assay Kit from Clontech,
USA) and also described in our previous study [43].
Apoptosis was also detected by visualizing fragmented
nucleus or apoptotic body formation under fluorescence
microscope as per our earlier method [43].
Image analysis
All images were analyzed using ImageJ software [45, 51].
Fluorescence intensities of the cells were measured by
ImageJ software and then it was calculated as intensity
per cell in all experiments and plotted.
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Statistical analysis
We evaluated the statistical significance for the irradi-
ated samples of each cell type with respect to the un-
irradiated control of each cell type using one way
ANOVA with Dunnett’s test from IBM SPSS Statistics
Version 21 software. The significance values were de-
noted as ‘*’ (0.01 < p ≤ 0.05), ‘**’ (0.001 < p ≤ 0.01) and ‘***’
(p ≤ 0.001). We did 2-tailed paired-samples T-test using
the same software to calculate the statistical significance
between H-vector and HsiI cells at a particular dose and
significance values were denoted as ‘#’ (0.01 < p ≤ 0.05),
‘##’ (0.001 < p ≤ 0.01) and ‘###’ (p ≤ 0.001) and also men-
tioned in the text. Each experiment was repeated at least
three times unless otherwise specified.
Results
PARP-1 expression in H-vector and HsiI cells
The protein expression of PARP-1 in knocked down
cells (HsiI) as well as in control H-vector was checked
by standard immunofluorescence (IF) technique as
shown in Fig. 1a. The expression level of PARP-1 was
normalized with respect to internal control beta actin.
Normalized PARP-1 expression in H-vector was taken as
100 % protein expression and subsequently PARP-1 level
in HsiI was calculated and plotted in Fig. 1b. Almost
75 % inhibition of PARP-1 expression was observed in
HsiI cells compared to H-vector.
Activity of MMP-2 and MMP-9 drastically reduces upon
PARP-1 depletion and it further diminishes when exposed
with carbon ion but not with gamma irradiation
MMP-2 and MMP-9 activities were detected by gelatin
zymography. A typical gelatin zymogram after carbon
ion and gamma exposure (0- 4 Gy) in both H-vector and
HsiI cells was shown in Fig. 2a and d respectively. Zones
of gelatinolytic activity of both MMP-2 and MMP-9
were found as clear bands with blue background (Fig. 2a
and d). Intensities of the bands representative to MMP-2
and MMP-9 were measured using ImageJ software. Band
intensity of un-irradiated H-vector was taken as 100 %
gelatinolytic activity (both MMP-2 and MMP-9) and ac-
cordingly activity at different dose of carbon ion or
gamma exposure with and without depletion of PARP-1
was calculated and plotted as shown in Fig. 2b, c, e and
f. All the data were normalized using loading control as
shown in Additional file 1. Carbon ion exposure reduced
activity of the both MMPs in a dose-dependent manner
in H-vector cells as shown in Fig. 2a, although extent of
reduction was higher for MMP-2. For example, MMP-2
and MMP-9 activity in H-vector cells was reduced to al-
most 30 % and 70 % at 4 Gy of carbon ion exposure.
Notably, about 75 % depletion of PARP-1 expression re-
duced about 70 % activity of MMP-2 and about 90 % ac-
tivity of MMP-9 in un-irradiated cells. Carbon ion
exposure further drastically reduced their activity lower
than 3 % in PARP-1 depleted cells as shown in Fig. 2a, b
and c. So, knocking down of PARP-1 gene synergized
high LET carbon ion exposure induced reduction of ac-
tivities of MMP-2 and MMP-9.
On the contrary, low LET gamma radiation enhanced the
activities of MMP-2 and MMP-9 in H-vector (0- 4 Gy) as
shown in Fig. 2d. The %activities are shown in Fig. 2e and f.
Depletion of PARP-1 reduced the MMP-2 and MMP-9 ac-
tivities as usual as shown in Fig. 2d. After gamma
Fig. 1 Checking of PARP-1 expression by IF study. a Typical photo-
graphs of immunostained H-vector & HsiI cells are given. Anti-PARP-1
antibody was detected by the secondary antibodies of FITC tagged
goat anti-mouse IgG1. DAPI was used to counterstain the nucleus.
Scale bar represents 20 μm. b Relative expression of PARP-1 was
calculated with respect to beta actin by measuring fluorescence
intensities by ImageJ software. PARP-1 expression in H-vector
was plotted as 100 % protein expression and accordingly PARP-1
level in HsiI was calculated and plotted. This experiment was
repeated four times. ‘###’ represents p ≤ 0.001
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irradiation HsiI cells did not show any significant en-
hancement of neither MMP-2 nor MMP-9 in our ex-
perimental condition as shown in Fig. 2e and f
respectively. It implies that PARP-1 inhibition can
protect the HeLa cells from being metastatic after
low LET gamma irradiation.
Role of PARP-1 on expression of MMP-2 and MMP-9 after
carbon ion exposure
We have monitored activity of MMPs as given in earlier
section. We also looked into the expression of these
MMPs inside the cell by western blot and standard im-
munofluorescence (IF) technique. Beta actin was used as
internal control. We observed a trend of slight decrease
of MMP-2 expression in H-vector but practically there
was no change in expression of MMP-2 in HsiI cells
with or without carbon ion exposure. A western blot
photograph of MMP-2 is shown in Fig. 3a. We have
measured band intensities of MMP-2 of western blots
and normalized with beta actin. Then normalized MMP-
2 expression in un-irradiated H-vector was taken as
100 % and subsequently others were calculated and plot-
ted in Fig. 3b. Almost similar pattern of expression of
MMP-2 was observed by IF studies as shown in Fig. 3c
and the IF images for MMP-2 expression were provided
as Additional file 2. Notably, IF study showed knocking
down of PARP-1 gene reduced expression of MMP-9 in
un-irradiated HsiI cells and after irradiation it was
increased dose-dependently as given in Fig. 3d and e,
although the exact mechanism is not clear to us. As such
there was no change in MMP-9 protein level in H-
vector after carbon ion exposure.
Expression of TIMP-1, TIMP-2 and TIMP-3 in cells after car-
bon ion exposure
In general, MMPs facilitate metastasis in a particular
cancer whereas TIMPs oppose it since TIMPs are en-
dogenous inhibitor of MMPs by nature. We monitored
the expression levels of TIMP-1, TIMP-2 and TIMP-3
by IF studies as shown in Fig. 4a, c and e. Here, beta
actin was used as internal control to calculate the rela-
tive protein levels. The respective normalized protein
level in un-irradiated H-vector was considered as
100 % expression and subsequently percentage of
others samples were calculated and plotted. Three
TIMPs showed different pattern of expression profile
in both the cell type after carbon ion exposure. Only
TIMP-1 expression increased dose-dependently
whereas TIMP-2 and TIMP-3 remained unaltered
after carbon ion exposure in H-vector as shown in
Fig. 4b, d and f. On the contrary, TIMP-1 and TIMP-3
increased dose-dependently in HsiI cells after carbon
ion exposure and their expression level was always sig-
nificantly greater in HsiI cells compared with that in
H-vector cells at higher doses (for TIMP-1 at and
above 2 Gy whereas for TIMP-3 at 4 Gy). TIMP-2 ex-
pression level was significantly higher in HsiI cells
compared with H-vector at all doses. These data im-
plicated that overall TIMPs expression was higher in
Fig. 2 Activity of MMP-2 and MMP-9 by gelatin zymography after carbon ion exposure and gamma (0- 4 Gy) irradiation. a Typical photograph of gel-
atin zymogram after 19 h of post-carbon ion exposure. The clear bands of MMP-9 (92 KDa) and MMP-2 (72 KDa) signify their gelatinolytic activity after
irradiation. ‘M’ marked lanes represent molecular weight marker. b & c The intensities of bands were measured by ImageJ software, normalized with
loading control (given as Additional file 1) and plotted. The intensities of the representative band of both MMP-2 & MMP-9 in un-irradiated H-vector
were considered as 100 % activity and accordingly the activity of the respective MMPs at different doses were calculated and plotted. d, e & f MMP-2
and MMP-9 activities are shown in H-vector and HsiI after gamma irradiation and representative bar diagram was prepared following the procedure as
mentioned above. ‘***’ on respective bar denotes p≤ 0.001 for activity at that dose compared with un-irradiated respective cell-type H-vector or HsiI.
‘###’ denotes p≤ 0.001 for difference of MMPs activities between H-vector and HsiI at a particular dose
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HsiI cells compared with H-vector after carbon ion ex-
posure at higher doses. However, expression of TIMP-
2 and TIMP-3 reduced significantly upon knocking
down of PARP-1 gene without any irradiation and the
reason is still unclear.
Apoptosis is the predominant mode of cell death after
carbon ion exposure
Cell death after carbon ion exposure was measured by dye
exclusion method using trypan blue. Dose-dependent in-
crease of cell death was observed after carbon ion
Fig. 3 Expression of MMP-2 and MMP-9 protein after carbon ion exposure (0- 4 Gy) in H-vector and HsiI cells. a Typical western blot of MMP-2
and beta actin (used as internal control). b Band intensities of western blot of MMP-2 were measured by ImageJ software and normalized with
respect to beta actin and plotted as % expression of MMP-2 considering MMP-2 expression in un-irradiated H-vector as 100 %. c Expression of
MMP-2 was also measured by IF technique. Intensities of the immunostained cells for MMP-2 were measured by ImageJ software, normalized
with respect to beta actin and plotted as mentioned above. Typical immunostained cells are shown in Additional file 2. d Expression of MMP-9
was measured by IF technique and typical immunostained cells are shown here. Scale bar represents 20 μm. e Intensities of the immunostained
cells for MMP-9 were measured by ImageJ software, normalized with respect to beta actin and plotted as mentioned above. Each bar diagram
represents the mean ± SD of three independent experiments
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exposure in both cell types, but HsiI showed significantly
higher sensitivity towards carbon ion exposure as shown
in Fig. 5a.
We checked two modes of cell death - autophagy and
apoptosis. Cleavage and lipidation of LC3B protein with
phosphatidylethanolamine occur during autophagosome
formation in cells undergoing autophagy and associates
with the phagophores. This lapidated LC3 is well known
as autophagy marker. In IF studies, it looks like vesicles
in cytoplasm expressing LC3B or cells undergoing au-
tophagy accumulate LC3 puncta. In our experimental
condition, we didn’t find any autophagic cell death after
carbon ion exposure in both H-vector and HsiI cells. No
noticeable accumulation of LC3 puncta was observed in
Fig. 4 Studies of TIMP-1, TIMP-2 and TIMP-3 protein expression by IF after carbon ion exposure (0- 4 Gy). a, c & e Immunostained cells using anti-TIMP-1,
anti-TIMP-2 and anti-TIMP-3 antibody followed by FITC conjugated host specific secondary antibody, are shown here respectively. DAPI was used to stain
nucleus. Scale bar denotes 20 μm. b, d & f Intensities of the immunostained cells for TIMP-1, TIMP-2 and TIMP-3 respectively were measured by ImageJ
software, normalized with beta actin. Normalized expression of respective protein in H-vector without irradiation was considered as 100 % expression of
that protein. Accordingly rest were calculated and plotted. Each bar diagram represents the mean ± SD of three independent experiments. ‘**’ & ‘***’ de-
note 0.01 < p≤ 0.05 & p≤ 0.001 respectively for TIMPs expression at each of the particular dose compared with un-irradiated cell-types. ‘#’ & ‘##’ denote
0.01 < p≤ 0.05 & 0.001 < p≤ 0.01 respectively for difference of TIMPs expression between H-vector and HsiI at a particular dose
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either cell-type with or without carbon ion exposure
as shown in Additional file 3a. But chloroquine di-
phosphate, an artificial inducer of autophagy, treated
H-vector cells showed the typical cytoplasmic vesicles
formation or LC3 puncta in our experimental condi-
tion as shown in Additional file 3b. So, our experi-
mental condition was able enough to detect any
autophagic cell death.
Then we measured fraction of cells undergoing apop-
totic death out of total cell death. At the late stage of
apoptosis, nucleus of the cell becomes fragmented and
condensed, forms characteristic apoptotic bodies. This is
one of the hallmarks of apoptosis. Here, we measured
nuclear fragmentation and it was increased dose-
dependently in both the H-vector and HsiI cells after
carbon ion exposure but it was always higher in HsiI
cells than H-vector. Typical photographs of undamaged
and fragmented nucleus are shown in Additional file 4a.
These fragmented nuclei for each cell-type were counted
and plotted to find % nuclear fragmentation as shown in
Fig. 5b. At 4 Gy total cell death was about 23 % in H-
vector and about 40 % in HsiI cells. Out of this total cell
death apoptosis contributed about 23 % in H-vector cells
and 33 % in HsiI cells. This data implicates that apop-
tosis is the predominant mode of cell death in each cell
type under our experimental condition. We also con-
firmed apoptosis by measuring caspase-3 activation
which was increased in a dose-dependent manner in
both H-vector and HsiI cells after carbon ion exposure
with respect to un-irradiated controls as shown in Fig. 5c.
HsiI cells exhibited greater caspase-3 activity than H-
vector suggesting HsiI cells showed more apoptosis in-
duction. The raw spectra of fluorescence representing
caspase-3 activity are also shown in Fig. 5d. We further
Fig. 5 Study of different modes of cell death. a % of cell death as detected by trypan blue staining after 19 h of post-carbon ion exposure and plotted.
Each bar diagram represents the mean ± SD of four independent experiments. b Detection of nuclear fragmentation. % nuclear fragmentation was
calculated and plotted. Each bar diagram represents the mean ± SD of four independent experiments. Typical image of fragmented nucleus is given in
Additional file 4a. c & d Assay of caspase-3 activity by fluorimetric study. Fluorimetric assay of caspase-3 activity of both H-vector and HsiI
cells after 20 h of post-carbon ion exposure is shown here (c). Each bar diagram represents the mean ± SD of three independent experiments.
The raw fluorescence spectra representing caspase-3 activity after carbon ion exposure is given here (d). e Caspase-3 activation by IF study. Fluorescence
intensities of caspase-3 immunostained cells in 20 h post-carbon ion exposure were measured by ImageJ software and plotted. Each bar diagram
represents the mean ± SD of three independent experiments. Typical photographs of immunostained cells are provided in Additional file 4b
Ghorai et al. Radiation Oncology  (2016) 11:126 Page 9 of 13
checked caspase-3 activation by standard IF technique
and observed the similar result as shown in Fig. 5e and
Additional file 4b.
Discussion
Conventional radiotherapy using gamma rays or X-rays
is facing various difficulties like it lacks dose-localization
to the target tumor cells, it grows radio-resistance, it is
not effective for hypoxic tumors or deep seated tumors
and importantly it triggers cancer metastasis by activat-
ing matrix metalloproteinases in various cancer cell-
types as discussed in the Background section. On the
contrary, high LET radiation or charged particles like
carbon ion has better potential to suppress metastatic
nature of cancer cells in vitro and in vivo [56, 57] includ-
ing its other beneficial roles over low LET radiations as
described earlier. But the detailed mechanism is not
clear. Earlier we observed that PARP-1, a crucial DNA
repair protein, plays regulatory roles in DNA damage re-
sponses after carbon ion exposure [43, 45]. Here, we
have shown that PARP-1 is coming up as a key player in
regulation of MMPs and TIMPs with or without carbon
ion exposure which can be useful to deal the metastasis
with a greater potential.
To check whether PARP-1 has any role in the regula-
tion of metastatic nature of cancer cells after treatment
with carbon ion exposure, we looked into the activities
and expression of two major matrix metalloproteinases,
MMP-2 and MMP-9, which are highly activated during
cancer metastasis. We found high LET carbon ion ex-
posure reduced both MMP-2 and MMP-9 activities
dose-dependently in H-vector. These findings corrobo-
rated with other study where charged particles including
carbon ion suppressed MMPs activities in vitro as well
as in vivo [58]. There was a trend of decreased expres-
sion of MMP-2 and unaltered expression of MMP-9
after carbon ion exposure in H-vector cells. But the in-
hibition of PARP-1 by shRNA reduced the activity of
MMP-2 and MMP-9 as well as the expression of MMP-
9 protein without irradiation. Several lines of evidence
supports our findings. PARP inhibitors like 5-AIQ and
PJ-34 inhibit MMP-2 activity in vitro [47]. Inhibition of
PARP with 5-AIQ down regulates the expression of
MMP-9 and MMP-2 as well as their activities via de-
creasing NF-kB expression, facilitating the suppression
of tumor metastasis in colorectal cancer [46]. But in our
case, there is no significant change in MMP-2 protein
level upon depletion of PARP-1 without any irradiation.
Interestingly, inhibition of PARP-1 by PJ-34 or siRNA
reduces the transcription of MMP-9 without changing
MMP-2 expression [48]. To avoid non-specific inter-
action of PARP inhibitors, if any, we approached our
studies using shRNA of PARP-1 and observed similar re-
sults as found from literature. Surprisingly, dose-
dependent increase of MMP-9 protein level is noticed in
HsiI cells although the enzymatic activity of the same is
totally lost. We do not know the reason. Interestingly,
Kauppinen and Swanson et al. showed PARP-1 activa-
tion facilitated MMP-9 release in the conditioned
medium of microglial culture [59]. So it could be pos-
sible in our experimental condition that in spite of in-
creased MMP-9 protein level, the activity of MMP-9
drastically reduced after carbon ion exposure due to the
inhibition of its release into the conditioned medium in
PARP-1 knocked down HsiI cells. However, the note-
worthy observation is carbon ion exposure to these HsiI
cells completely abolishes the activities of both MMP-2
and MMP-9 in almost all doses. This is the first report
to show synergistic reduction of activities of MMPs by
carbon ion exposure in combination with PARP-1 inhib-
ition. Gamma irradiation significantly enhanced both
MMP-2 and MMP-9 activities in H-vector cells support-
ing the previous reports as mentioned in Background
section. But, PARP-1 depletion did not show any signifi-
cant enhancement of MMPs activities after gamma ir-
radiation in our experimental condition, implicating the
beneficial role of PARP-1 inhibition in gamma therapy.
So, our data implicates that better anti-metastatic effect
can be obtained for cervical cancer cells when PARP-1
inhibition is combined with carbon ion exposure.
There are various other factors related to the metastatic
potential of cancer cells. Out of those, the TIMPs – the
endogenous inhibitors of MMPs, are also very crucial can-
didates to control metastasis. Here, we measured TIMP-1,
TIMP-2 and TIMP-3 protein expression by IF technique
in both H-vector and HsiI cell types with or without car-
bon ion exposure. Previous reports show the up-
regulation of TIMP-1 in different cell types using low LET
ionizing radiations as well as particle radiations [27, 34].
TIMP-1 over-expression radio-sensitizes the renal cancer
cells to gamma radiation and also shows elevation of
TIMP-2 protein level as well as decrease of MMP-2 activ-
ity [29]. On the contrary, there are other reports opposing
these observations. One investigation demonstrates no
significant change in TIMP-1 and TIMP-2 in Panc-1, pan-
creatic cancer cells after gamma irradiation [28]. Again,
low LET ionizing radiation has no effect on TIMP-2 ex-
pression in human lung epithelial cells [24]. Since the low
LET radiation and high LET carbon ion exposure are to-
tally different in terms of their physical properties, they
show different biological effects. Very little is known about
cellular responses against high LET carbon ion exposure.
Our results show that up-regulation of TIMP-1 after car-
bon ion exposure although expression of TIMP-2 and 3
remains the same in H-vector cells. But, dose-dependent
increase of TIMP-1 and TIMP-3 is observed in HsiI cells
and their expressions are significantly higher in HsiI cells
than that in H-vector at higher dose such as at 4 Gy.
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Furthermore, TIMP-2 expression is significantly higher in
HsiI than H-vector at all doses. It is to be noted that
TIMP-1 and TIMP-2 are the endogenous inhibitors of
MMP-9 and MMP-2 respectively. So their up-regulation
might be explained with the reduction of respective
MMPs activities, although we didn’t check the activities of
TIMPs in our experimental conditions. This data further
implicates that overall anti-metastatic effect as detected by
higher expression of TIMPs obtained by combination of
PARP-1 inhibition with carbon ion exposure is far better
than that by carbon ion exposure alone. In other words,
PARP-1 inhibition potentiates anti-metastatic effect of car-
bon ion exposure in terms of reduced activities of MMPs
and higher expression of TIMPs. Our work further raises
few interesting questions which remained unexplored.
The expression patterns of all three TIMPs are different
after carbon ion exposure with or without PARP-1 inhib-
ition. We do not know why TIMP-2 and TIMP-3 are
down-regulated in PARP-1 knocked down cells without
any radiation. TIMP-1 remains unchanged after knocking
down of PARP-1 gene in our experimental condition.
However, decreased transcription of TIMP-1 is noticed
after PARP-1 inhibition by inhibitor or siRNA in cardiac
fibroblasts [48]. It is found that deletion or knockout of
PARP-1 gene enhances TIMP-2 expression as detected by
RT-PCR [60, 61], although they do not mention the pro-
tein level of TIMP-1 and TIMP-2. PARP-1 gene deletion
can increase the expression of TIMP-3 to a lower extent
whereas status of TIMP-3 in protein level is not reported
[61]. We observe carbon ion exposure up-regulates
TIMP-3 level dose-dependently in HsiI cells but not H-
vector and expression of TIMP-3 is significantly higher in
HsiI cells than H-vector at 4 Gy. TIMP-3 is reported to in-
crease apoptosis upon over-expression [62]. In another
study, overexpression of TIMP-3 in HeLa carcinoma cell
line induces a FADD-dependent type II apoptotic signal-
ing pathway [63]. Hence, increased level of TIMP-3 in
HsiI cells can be associated with higher apoptosis induc-
tion after carbon ion exposure. Moreover, we showed
knocking down of PARP-1 can also activate extrinsic path-
way of apoptosis more than the wild type after carbon ion
exposure in our previous study [45].
Furthermore, we investigated the mode of cell death
taken by the cells when the metastatic potential was
compromised upon knocking down of PARP-1 with
combination of carbon ion exposure. We mainly
checked apoptosis and autophagy induction. HsiI cells
having lower MMPs activities showed higher amount of
apoptosis induction in terms of caspase-3 activation and
nuclear fragmentation than H-vector after irradiation
with carbon ion exposure, consistent with our previous
reports [43, 45]. Notably, we observe that % cell death,
as detected by trypan blue is comparable or slightly
higher than % nuclear fragmentation after irradiation
with carbon ion exposure. This data implicates that most
of the cells dies through apoptosis pathway after carbon
ion exposure. Surprisingly, we do not see any significant
amount of autophagy after carbon ion exposure in both
cell types in our experimental condition. But there are
reports where carbon ion exposure induced autophagy
[64, 65] and PARP-1 is also involved in autophagic cell
death [66, 67]. Our data shows apoptosis is the major
mode of cell death after carbon ion exposure in combin-
ation with PARP-1 depletion.
Conclusions
Our results suggest that PARP-1 depletion along with car-
bon ion exposure synergistically increases apoptosis and
decreases metastatic properties via reducing activities
of both MMP-2 and MMP-9 and overall up-regulation
of TIMP-1, TIMP-2 and TIMP-3 in HeLa cells. PARP-1
inhibition has beneficial role via stopping increase of
metastatic property induced by gamma irradiation. So,
PARP-1 inhibition in combination with carbon ion
exposure could be a promising tool in hadrontherapy
for treatment of cervical or other cancers and could be
beneficial in post-irradiation stages by stopping
metastasis.
Additional files
Additional file 1: Loading control of gelatin zymography. a A
representative gel image of SDS-PAGE without gelatin run parallel to
the gelatin zymography gel with same amount of samples under same
experimental condition as given in Fig. 2a after carbon ion exposure
(0- 4 Gy) is shown here. This was treated as loading control for
normalization of the band intensities from the zymography gel to get
the MMPs activities. ‘M’ denotes the molecular weight marker lane. b A
representative gel image of loading control for gamma irradiated
samples as given in Fig. 2d. (TIF 220 kb)
Additional file 2: MMP-2 expression after carbon ion exposure (0- 4 Gy)
by IF. Typical photographs of immunostained cells of both H-vector and
HsiI are shown here. Mouse anti-MMP-2 primary antibody was used,
followed by the secondary antibody of FITC tagged goat anti-mouse IgG1
to detect the MMP-2 expression. DAPI was used to stain the nucleus.
Scale bar represents 20 μm. (TIF 484 kb)
Additional file 3: Detection of autophagy by IF. a Typical photograph of
immunostained H-vector and HsiI cells with LC3B polyclonal antibody
detected by donkey anti-rabbit IgG-R (tagged with Rhodamine) after carbon
ion exposure at 4 Gy is given here and DAPI is used to stain nucleus. b
Typical photograph of H-vector cells undergoing autophagy after treatment
with 50 μM chloroquine diphosphate for 16 h at 37 °C followed by
immunostaining with LC3B polyclonal antibody is shown here as
positive control. Scale bar represents 20 μm. One representative cell
is zoomed to show the LC3 puncta. (TIF 718 kb)
Additional file 4: Apoptosis induction after carbon ion exposure (0- 4 Gy). a
Detection of nuclear fragmentation. Typical photographs of undamaged
nuclei and fragmented nuclei of H-vector and HsiI cells irradiated with 4 Gy of
carbon ion exposure after staining with Hoechst dye are shown here. One
representative cell is zoomed to show the fragmented nucleus or apoptotic
bodies. b Typical photographs of immunostained cells of caspase-3 (Casp-3)
activation in both H-vector and HsiI as detected by standard IF technique are
shown here. Rabbit anti-Casp-3 antibody was detected by the secondary
antibody of Rhodamine tagged (Rhd) donkey anti-rabbit IgG. DAPI was used
to counterstain the nucleus. Scale bar represents 20 μm. (TIF 947 kb)
Ghorai et al. Radiation Oncology  (2016) 11:126 Page 11 of 13
Abbreviations
DAPI: 4’, 6-diamidino-2-phenylindole; FITC: Fluorescein isothiocyanate;
IF: Immunofluorescence; LET: Linear energy transfer; MMPs: Matrix
metalloproteinases; PARP-1: Poly (ADP-ribose) polymerase-1; SD: Standard
deviation; TIMPs: Tissue inhibitor of matrix metalloproteinases
Acknowledgements
UG is grateful to Saha Institute of Nuclear Physics (SINP), Kolkata, India for
providing facility of gamma radiation and cell culture facility in post-
irradiation incubation.
Funding
UG & AG are both grateful to Indian Council of Medical Research (ICMR),
New Delhi, India for partial financial support and AG personally
acknowledges ICMR (45/19/2010- BMS/CMB) for his senior research
fellowship. UG thanks Inter-University Accelerator Centre (IUAC), New Delhi,
India for partial financial support as well as for availing instrumental facility of
carbon ion exposure. UG thanks DBT for instrumental support under project
BT/PR 4809/BRB/10/1028/2012.
Availability of data and materials
All data generated or analysed during this study are included in this
published article including its supplementary information files.
Authors’ contributions
UG and AG conceived the study, designed the experiments, critically
discussed the data and drafted the manuscript. AG carried out all the
experiments, data acquisition and the statistical analysis, except gamma
radiation related work. AS contributed his technical know-how for availing
high LET carbon ion exposure with desired doses. PC did gamma related
works. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Author details
1Department of Biochemistry & Biophysics, University of Kalyani, Kalyani
741235, India. 2Inter-University Accelerator Center (IUAC), Aruna Asaf Ali
Marg, New Delhi 110067, India. 3Present address: Department of Biological
Sciences, Tata Institute of Fundamental Research (TIFR), Homi Bhabha Road,
Colaba, Mumbai 400005, India.
Received: 27 February 2016 Accepted: 13 September 2016
References
1. Weiss L. Metastatic inefficiency. Adv Cancer Res. 1990;54:159–211.
2. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges.
Nat Med. 2006;12:895–904.
3. Chia JS, Du JL, Hsu WB, Sun A, Chiang CP, Wang WB. Inhibition of
metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail
Tien-Hsien Liquid. BMC Cancer. 2010;10:175.
4. Bjorklund M, Koivunen E. Gelatinase-mediated migration and invasion of
cancer cells. Biochim Biophys Acta. 2005;1755:37–69.
5. Duffy MJ, McGowan PM, Gallagher WM. Cancer invasion and metastasis:
changing views. J Pathol. 2008;214:283–93.
6. Overall CM, Kleifeld O. Tumour microenvironment—opinion: validating
matrix metalloproteinases as drug targets and anti-targets for cancer
therapy. Nat Rev Cancer. 2006;6:227–39.
7. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic
potential correlates with enzymatic degradation of basement membrane
collagen. Nature. 1980;284:67–8.
8. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V.
Induction of cell migration by matrix metalloproteinase-2 cleavage of
laminin-5. Science. 1997;277:225–8.
9. Turpeenniemi-Hujanen T, Thorgeirsson UP, Hart IR, Grant SS, Liotta LA. Expression
of collagenase IV (basement membrane collagenase) activity in murine tumor
cell hybrids that differ in metastatic potential. J Natl Cancer Inst. 1985;75:99–108.
10. Stetler-Stevenson WG, Hewitt R, Corcoran M. Matrix metalloproteinases and
tumor invasion: from correlation and causality to the clinic. Semin Cancer
Biol. 1996;7:147–54.
11. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G.
Biochemistry and molecular biology of gelatinase B or matrix
metalloproteinase-9 (MMP-9). Crit Rev BiochemMol Biol. 2002; 37:375–536.
12. Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and
tissue inhibitors of metalloproteinases (TIMPs): Positive and negative
regulators in tumor cell adhesion. Semin Cancer Biol. 2010;20:161–8.
13. Libra M, Scalisi A, Vella N, Clementi S, Sorio R, Stivala F, Spandidos DA,
Mazzarino C. Uterine cervical carcinoma: role of matrix metalloproteinases
(review). Int J Oncol. 2009;34:897–903.
14. Sheu BC, Lien HC, Ho HN, Lin HH, Chow SN, Huang SC, Hsu SM. Increased
expression and activation of gelatinolytic matrix metalloproteinases is
associated with the progression and recurrence of human cervical cancer.
Cancer Res. 2003;63:6537–42.
15. Wang PH, Ko JL, Tsai HT, Yang SF, Han CP, Lin LY, Chen GD. Clinical
significance of matrix metalloproteinase-2 in cancer of uterine cervix: a
semiquantitative study of immunoreactivities using tissue array. Gynecol
Oncol. 2008;108:533–42.
16. Yang SF, Wang PH, Lin LY, Ko JL, Chen GD, Yang JS, Lee HS, Hsieh YS. A
significant elevation of plasma level of matrix metalloproteinase-9 in
patients with high-grade intraepithelial neoplasia and early squamous cell
carcinoma of the uterine cervix. Reprod Sci. 2007;14:710–8.
17. Rauvala M, Aglund K, Puistola U, Turpeenniemi-Hujanen T, Horvath G, Willén R,
Stendahl U. Matrix metalloproteinases-2 and -9 in cervical cancer: different
roles in tumor progression. Int J Gynecol Cancer. 2006;16:1297–302.
18. Nasr M, Ayyad SB, El-Lamie IK, Mikhail MY. Expression of matrix
metalloproteinase-2 in preinvasive and invasive carcinoma of the uterine
cervix. Eur J Gynaecol Oncol. 2005;26:199–202.
19. Talvensaari-Mattila A, Turpeenniemi-Hujanen T. Matrix metalloproteinase 9 in the
uterine cervix during tumor progression. Int J Gynaecol Obstet. 2006;92:83–4.
20. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer
J Clin. 2005;55:74–108.
21. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine.
2006;24:S11–25.
22. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV
infection: unresolved issues. Nat Rev Cancer. 2007;7:11–22.
23. Park CM, Park MJ, Kwak HJ, Lee HC, Kim MS, Lee SH, Park IC, Rhee CH, Hong
SI. Ionizing radiation enhances matrix metalloproteinase-2 secretion and
invasion of glioma cells through Src/epidermal growth factor receptor-
mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling
pathways. Cancer Res. 2006;66:8511–9.
24. Araya J, Maruyama M, Sassa K, Fujita T, Hayashi R, Matsui S, Kashii T,
Yamashita N, Sugiyama E, Kobayashi M. Ionizing radiation enhances matrix
metalloproteinase-2 production in human lung epithelial cells. Am J Physiol
Lung Cell Mol Physiol. 2001;280:L30–8.
25. Strup-Perrot C, Vozenin-Brotons MC, Vandamme M, Benderitter M, Mathe D.
Expression and activation of MMP-2,-3,-9,-14 are induced in rat colon after
abdominal X-irradiation. Scand J Gastroenterol. 2006;41:60–70.
26. Yang K, Liu L, Zhang T, Wu G, Ruebe C, Ruebe C, Hu Y. TGF-beta1 transgenic
mouse model of thoracic irradiation: modulation of MMP-2 and MMP-9 in the
lung tissue. J Huazhong Univ Sci Technolog Med Sci. 2006;26:301–4.
27. Nirmala C, Jasti SL, Sawaya R, Kyritsis AP, Konduri SD, Ali-Osman F, Rao
JS, Mohanam S. Effects of radiation on the levels of MMP-2, MMP-9 and
TIMP-1 during morphogenic glial-endothelial cell interactions. Int J
Cancer. 2000;88:766–71.
28. Kim NY, Lee JE, Chang HJ, Lim CS, Nam DH, Min BH, Park GH, Oh JS.
Gamma- irradiation enhances RECK protein levels in Panc-1 pancreatic
cancer cells. Mol Cells. 2008;25:105–11.
29. Smyth A, Reid HM, Baker AH, McGlynn H. Modifications of the
radiosensitivity of a renal cancer cell line as a consequence of stable TIMP-1
overexpression. Int J Radiat Biol. 2007;83:13–25.
30. Chuanling G, Jufang W, Xiaodong J, Xigang J, Renmin L, Wei W, Wenjian L.
Studies on advantages of heavy ions in radiotherapy compared with γ-rays.
Nucl Instr and Meth in Phys Res B. 2007;259:997–1003.
31. Okayasu R. Repair of DNA damage induced by accelerated heavy ions- a
mini review. Int J Cancer. 2011;130:991–1000.
Ghorai et al. Radiation Oncology  (2016) 11:126 Page 12 of 13
32. Takahashi Y, Teshima T, Kawaguchi N, et al. Heavy ion irradiation inhibits in
vitro angiogenesis even at sublethal dose. Cancer Res. 2003;63:4253–7.
33. Ogata T, Teshima T, Kagawa K, Hishikawa Y, et al. Particle irradiation
suppresses metastatic potential of cancer cells. Cancer Res. 2005;65:113–20.
34. Tian J, Pecaut MJ, Coutrakon GB, Slater JM, Gridley DS. Response of
extracellular matrix regulators in mouse lung after exposure to photons,
protons and simulated solar particle event protons. Radiat Res. 2009;172:30–41.
35. Dantzer F, de La Rubia G, Menissier-De Murcia J, Hostomsky Z, de Murcia G,
Schreiber V. Base excision repair is impaired in mammalian cells lacking
Poly(ADP-ribose)polymerase-1. Biochemistry. 2000;39:7559–69.
36. Masutani M, Fujimori H. Poly(ADP-ribosyl)ation in carcinogenesis. Mol
Aspects Med. 2013;34:1202–16.
37. Calabrese CR, Almassy R, Barton S, Batey MA, Calvert AH, Canon-koch S,
Durkcz BW, Hostomsky Z, et al. Anticancer chemopotentiation and
radiosensitization by the novelpoly(ADP-ribose) polymerase-1 inhibitor
AG14361. J Natl Cancer Inst. 2004;96:56–67.
38. Lupo B, Trusolino L. Inhibition of poly(ADP-ribosyl)ation in cancer: Old and
new paradigms revisited. Biochim Biophys Acta. 2014;1846:201–15.
39. Lee JM, Ledermann JA, Kohn EC. PARP inhibitors for BRCA1/2 mutation-
associated and BRCA-like malignancies. Ann Oncol. 2014;25:32–40.
40. Curtin NJ, Szabo C. Therapeutic applications of PARP inhibitors: anticancer
therapy and beyond. Mol Aspects Med. 2013;34:1217–56.
41. Hay T, Matthews JR, Pietzka L, Lau A, Cranston A, Nygren AO, Douglas-Jones
A, Smith GC, Martin NM, O’Connor M, Clarke AR. Poly(ADP-ribose)
polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-
mutant mammary tumors in vivo and delays tumor relapse in combination
with carboplatin. Cancer Res. 2009;69:3850–5.
42. Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P,
Swaisland H, Lau A, O’Connor MJ, Ashworth A, Carmichael J, Kaye SB,
Schellens JH, de Bono JS. Inhibition of poly(ADP-ribose) polymerase in
tumors from BRCA mutation carriers. N Engl J Med. 2009;361:123–34.
43. Ghorai A, Bhattacharyya NP, Sarma A, Ghosh U. Radiosensitivity and
induction of apoptosis by high LET carbon ion beam and low LET gamma
radiation: a comparative study. Scientifica. 2014;2014:438030.
44. Takahisa H, Hidenori S, Hiroaki F, Ryuichi O, Keisuke S, Mitsuko M.
Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells
exposed to low and high liner energy transfer radiation. Cancer Sci. 2012;
103:1045–50.
45. Ghorai A, Sarma A, Bhattacharyya NP, Ghosh U. Carbon ion beam triggers
both caspase-dependent and caspase-independent pathway of apoptosis in
HeLa and expression level of PARP-1 controls overall intensity of apoptosis.
Apoptosis. 2015;20:562–80.
46. Li M, Threadgill MD, Wang Y, Cai L, Lin X. Poly(ADP-ribose) polymerase
inhibition down-regulates expression of metastasis-related genes in CT26
colon carcinoma cells. Pathobiology. 2009;76:108–16.
47. Nicolescu AC, Holt A, Kandasamy AD, Pacher P, Schulz R. Inhibition of matrix
metalloproteinase-2 by PARP inhibitors. Biochem Biophys Res Commun.
2009;387:646–50.
48. Huang D, Wang Y, Yang C, Liao Y, Huang K. Angiotensin II promotes
poly(ADP-ribosyl)ation of c-Jun/c-Fos in cardiac fibroblasts. J Mol Cell
Cardiol. 2009;46:25–32.
49. Kthari A, Barua P, Archunan M, Rani K, Subramanian ET, Pujari G, Kaur H,
Satyanarayanan VVV, Sarma A, Avasthi DK. ASPIRE: An automated sample
positioning and irradiation system for radiation biology experiments at Inter
University Accelerator Centre, New Delhi. Radiat Meas. 2015;76:17–22.
50. Zhai Y, Hotary KB, Nan B, Bosch FX, Munoz N, Weiss SJ, Cho KR. Expression
of membrane type 1 matrix metalloproteinase is associated with cervical
carcinoma progression and invasion. Cancer Res. 2005;65:6543–50.
51. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of
image analysis. Nat Methods. 2012;9:671–5.
52. Ghosh U, Bhattacharyya NP. Benzamide and 4-amino 1, 8 naphthalimide
treatment inhibit telomerase activity by down-regulating the expression of
telomerase associated protein and inhibiting poly(ADP-ribosyl)ation of
telomerase reverse transcriptase in cultured cells. FEBS J. 2005;272:4237–48.
53. Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and
signaling regulation. Curr Opin Cell Biol. 2010;22:124–31.
54. Kroemer G, Marino G, Levine B. Autophagy and the integrated stress
response. Mol Cell. 2010;40:280–93.
55. Ho H, Kapadia R, Al-Tahan S, Ahmad S, Ganesan AK. WIPI1 coordinates
melanogenic gene transcription and melanosome formation via TORC1
inhibition. J Biol Chem. 2011;286:12509–23.
56. Akino Y, Teshima T, Kihara A, Kodera-Suzumoto Y, Inaoka M, Higashiyama S,
Furusawa Y, Matsuura N. Carbon-ion beam irradiation effectively suppresses
migration and invasion of human non-small-cell lung cancer cells. Int J
Radiat Oncol Biol Phys. 2009;75:475–81.
57. Liu Y, Liu Y, Zhang H, Sun C, Zhao Q, Di C, Li H, Gan L, Wang Y. Effects of
carbon-ion beam irradiation on the angiogenic response in lung
adenocarcinoma A549 cells. Cell Biol Int. 2014;11:1304–10.
58. Ogata T, Teshima T, Kagawa K, Hishikawa Y, Takahashi Y, Kawaguchi A,
Suzumoto Y, Nojima K, Furusawa Y, Matsuura N. Particle irradiation
suppresses metastatic potential of cancer cells. Cancer Res. 2005;65:113–20.
59. Kauppinen TM, Swanson RA. Poly(ADP-ribose) polymerase-1 promotes
microglial activation, proliferation, and matrix metalloproteinase-9-mediated
neuron death. J Immunol. 2005;174:2288–96.
60. Hans CP, Feng Y, Naura AS, Troxclair D, Zerfaoui M, Siddiqui D, Jihang J, Kim
H, Kaye AD, Matrougui K, Lazartigues E, Boulares AH. Opposing roles of
PARP-1 in MMP-9 and TIMP-2 expression and mast cell degranulation in
dyslipidemic dilated cardiomyopathy. Cardiovasc Pathol. 2010;20:e57–68.
61. Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S,
Fallon K, Woods C, Boulares AH. Poly(ADP-ribose) polymerase inhibition
reduces atherosclerotic plaque size and promotes factors of plaque stability
in apolipoprotein E-deficient mice. Circulation. 2007;115:2442–50.
62. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue
inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular
smooth muscle cell invasion, proliferation, and death in vitro. J Clin Invest.
1998;101:1478–87.
63. Bond M, Murphy G, Bennett MR, Newby AC, Baker AH. Tissue inhibitor of
metalloproteinase-3 induces a Fas-associated death domain-dependent
type II apoptotic pathway. J Biol Chem. 2002;277:13787–95.
64. Jin X, Liu Y, Ye F, Liu X, Furusawa Y, Wu Q, Li F, Zheng X, Dai Z, Li Q. Role of
autophagy in high linear energy transfer radiation-induced cytotoxicity to
tumor cells. Cancer Sci. 2014;105:770–8.
65. Jin X, Li F, Zheng X, Liu Y, Hirayama R, Liu X, Li P, Zhao T, Dai Z, Li Q.
Carbon ions induce autophagy effectively through stimulating the unfolded
protein response and subsequent inhibiting Akt phosphorylation in tumor
cells. Sci Rep. 2015;5:13815.
66. Mu-oz-Gámez JA, Rodríguez-Vargas JM, Quiles-Pérez R, Aguilar-Quesada R,
Martín-Oliva D, de Murcia G, Ménissier de Murcia J, Almendros A, Ruiz de
Almodóvar M, Oliver FJ. PARP-1 is involved in autophagy induced by DNA
damage. Autophagy. 2009;5:61–74.
67. Rodriguez-Vargas JM, Ruiz-Magana MJ, Ruiz-Ruiz C, Majuelos-Melguizo J,
Peralta- Leal A, Rodriguez MI, Munoz-Gamez JA, de Almodovar MR, Siles E,
Rivas AL, Jaattela M, Oliver FJ. ROS-induced DNA damage and PARP-1 are
required for optimal induction of starvation-induced autophagy. Cell Res.
2012;22:1181–98.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Ghorai et al. Radiation Oncology  (2016) 11:126 Page 13 of 13
